Your browser doesn't support javascript.
loading
Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB.
Van Deun, A; Decroo, T; Kuaban, C; Noeske, J; Piubello, A; Aung, K J M; Rieder, H L.
Afiliação
  • Van Deun A; International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.
  • Decroo T; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Research Foundation Flanders, Brussels, Belgium.
  • Kuaban C; Faculty of Health Sciences, University of Bamenda, Bamenda.
  • Noeske J; Independent Consultant, Douala, Cameroon.
  • Piubello A; International Union Against Tuberculosis and Lung Disease, Paris, France, Damien Foundation, Brussels, Belgium.
  • Aung KJM; Damien Foundation Bangladesh, Dhaka, Bangladesh.
  • Rieder HL; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Tuberculosis Consultant Services, Kirchlindach, Switzerland.
Int J Tuberc Lung Dis ; 23(9): 965-971, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31615602

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Levofloxacino / Moxifloxacina / Gatifloxacina / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como assunto: Africa / Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Levofloxacino / Moxifloxacina / Gatifloxacina / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como assunto: Africa / Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article